created a recombinant bifunctional IL-4/IL-13 antagonist that in a mouse of model of asthma reduced not only IL-4–dependent increase in serum IgE levels but also IL-13–dependent airway hyper-responsiveness and lung inflammation (132). The gene discussed is IL13; the disease is asthma.